Home » News

Back

News Articles

KBroVet®-CA1 Receives Conditional FDA Approval

KBroVet®-CA1 Receives Conditional FDA Approval

The US Food and Drug Administration has granted KBroVet®-CA1 (potassium bromide chewable tablets) conditional approval for veterinary use in the management of seizures in dogs with idiopathic epilepsy. PRN® Pharmacal developed KBroVet-CA1 to provide a consistent and...

read more

Categories